Literature DB >> 345805

Fatal viscerotropic Rocky Mountain spotted fever. Report of a case diagnosed by immunofluorescence.

W R Green, D H Walker, B G Cain.   

Abstract

A case of fatal viscerotropic Rocky Mountain spotted fever with virtual absence of cutaneous lesions was diagnosed at autopsy by specific immunofluorescent demonstration of Rickettsia rickettsii in spleen, kidney, epididymis and skin. The clinical presentation was that of insidious onset of fever, renal failure, hypotension, hyponatremia and obtundation over a 10 day period. The patient had respiratory insufficiency, hypocalcemia, increases in creatinine phosphokinase (CPK), serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), lactic dehydrogenase (LDH), alkaline phosphatase, billirubin and serum phosphate, grand mal seizure, myalgia and unremitting shock with death occurring on day 12 of illness. Postmortem examination revealed severe vasculitis with interstitial nephritis and multifocal tubular necrosis, pericholangitis with bile stasis, glial nodules in the brain, multifocal rhabdomyonecrosis, interstitial pneumonitis and mild interstitial myocarditis. Risk factors which this patient shared with other patients with fatal Rocky Mountain spotted fever were failure to recognize a rash, failure to obtain a tick bite history, male sex, black race and age greater than 30 years.

Entities:  

Mesh:

Year:  1978        PMID: 345805     DOI: 10.1016/0002-9343(78)90247-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Superoxide dismutase-dependent, catalase-sensitive peroxides in human endothelial cells infected by Rickettsia rickettsii.

Authors:  J E Hong; L A Santucci; X Tian; D J Silverman
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 2.  Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

3.  Routine argyrophil techniques detect Rickettsia rickettsii in tissues of patients with fatal Rocky Mountain spotted fever.

Authors:  Christopher D Paddock; Jeanine H Sanders; Amy M Denison; Atis Muehlenbachs; Sherif R Zaki
Journal:  J Histotechnol       Date:  2016-12-12       Impact factor: 0.714

Review 4.  Rocky Mountain spotted fever: a disease in need of microbiological concern.

Authors:  D H Walker
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

5.  Diagnosis of Mediterranean spotted fever by cultivation of Rickettsia conorii from blood and skin samples using the centrifugation-shell vial technique and by detection of R. conorii in circulating endothelial cells: a 6-year follow-up.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  Successful treatment of Rocky Mountain 'spotless' fever.

Authors:  P G Ramsey; O W Press
Journal:  West J Med       Date:  1984-01

7.  Development and characterization of high-titered, group-specific fluorescent-antibody reagents for direct identification of rickettsiae in clinical specimens.

Authors:  G A Hébert; T Tzianabos; W C Gamble; W A Chappell
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

8.  Kidney lesions in Rocky Mountain spotted fever: a light-, immunofluorescence-, and electron-microscopic study.

Authors:  W D Bradford; B P Croker; C C Tisher
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

9.  Potential for free radical-induced lipid peroxidation as a cause of endothelial cell injury in Rocky Mountain spotted fever.

Authors:  D J Silverman; L A Santucci
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.